PT Millennium Pharmacon International Tbk
SDPC
Rank in Stocks
#27752
PT Millennium Pharmacon International Tbk is an Indonesian enterprise... PT Millennium Pharmacon International Tbk is an Indonesian enterprise specializing in the wholesale and provision of a diverse range of healthcare products. This includes both prescription and over-the-counter medicines, nutritional supplements, and medical equipment. The company's comprehensive distribution channels extend to various points of sale, such as retail pharmacies, hospitals, supermarkets, and other retail establishments. As of December 31, 2021, it managed 33 regional offices strategically located across Indonesia's major islands, including Java, Bali, Sumatera, Kalimantan, and Sulawesi. Founded in 1952, the organization was originally known as PT NVPD Soedarpo Corporation Tbk before adopting its current designation, PT Millennium Pharmacon International Tbk, in February 1990. Its corporate headquarters are situated in Jakarta Selatan, Indonesia, and it operates as a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Share Price
$0.01074658
Last synced: 2026-11-10
Market Cap
$13.69M
Change (1 day)
7.78%
Change (1 year)
31.01%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Millennium Pharmacon International Tbk (SDPC)
Category
Healthcare
EPS for PT Millennium Pharmacon International Tbk (SDPC)
EPS as of June 2026 TTM: $0.00
According to PT Millennium Pharmacon International Tbk's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for PT Millennium Pharmacon International Tbk from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 125.00% |
| 2025 | 0.00 | 125.00% |
| 2024 | 0.00 | -52.94% |
| 2023 | 0.00 | 41.67% |
| 2022 | 0.00 | 140.00% |
| 2021 | 0.00 | 150.00% |
| 2020 | 0.00 | -50.00% |
| 2019 | 0.00 | -63.64% |
| 2018 | 0.00 | -21.43% |
| 2017 | 0.00 | 27.27% |
| 2016 | 0.00 | -8.33% |
| 2015 | 0.00 | 50.00% |
| 2014 | 0.00 | -27.27% |
| 2013 | 0.00 | -21.43% |
| 2012 | 0.00 | 180.00% |
| 2011 | 0.00 | 150.00% |
| 2010 | 0.00 | -85.71% |
| 2009 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 2,169,344.44% |
US
|
|
| $17.99 | 999,344.44% |
US
|
|
| $7.77 | 431,566.67% |
US
|
|
| $17.99 | 999,344.44% |
US
|
|
| $0.04 | 2,316.67% |
AU
|
Questions about PT Millennium Pharmacon International Tbk's earnings per share (EPS)
What is PT Millennium Pharmacon International Tbk's earnings per share (EPS)?
PT Millennium Pharmacon International Tbk's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was PT Millennium Pharmacon International Tbk's earnings per share (EPS) in 2025?
In 2025, PT Millennium Pharmacon International Tbk's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has PT Millennium Pharmacon International Tbk's earnings per share (EPS) changed since 2020?
From 2020 to 2025, PT Millennium Pharmacon International Tbk's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does PT Millennium Pharmacon International Tbk's earnings per share (EPS) compare with similar companies?
PT Millennium Pharmacon International Tbk's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.